Article ID Journal Published Year Pages File Type
3391387 Seminars in Immunology 2014 9 Pages PDF
Abstract

•CB1 receptor signaling is mobilized by acute stress and serves to dampen the endocrine responses.•Chronic variable stress down-regulates CB1 receptor signaling in the hippocampus and ventral striatum.•Increased CB1 receptor signaling contributes to habituation of endocrine and some behavioral responses to repeated stress.•Reduced CB1 receptor signaling exacerbates the effects of stress and may contribute to its negative consequences.

The CB1 cannabinoid receptor is a G protein coupled receptor that is widely expressed throughout the brain. The endogenous ligands for the CB1 receptor (endocannabinoids) are N-arachidonylethanolamine and 2-arachidonoylglycerol; together the endocannabinoids and CB1R subserve activity dependent, retrograde inhibition of neurotransmitter release in the brain. Deficiency of CB1 receptor signaling is associated with anhedonia, anxiety, and persistence of negative memories. CB1 receptor-endocannabinoid signaling is activated by stress and functions to buffer or dampen the behavioral and endocrine effects of acute stress. Its role in regulation of neuronal responses is more complex. Chronic variable stress exposure reduces endocannabinoid-CB1 receptor signaling and it is hypothesized that the resultant deficiency in endocannabinoid signaling contributes to the negative consequences of chronic stress. On the other hand, repeated exposure to the same stress can sensitize CB1 receptor signaling, resulting in dampening of the stress response. Data are reviewed that support the hypothesis that CB1 receptor signaling is stress responsive and that maintaining robust endocannabinoid/CB1 receptor signaling provides resilience against the development of stress-related pathologies.

Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
,